SCHEMBL7418535

SCHEMBL7418535

NCc1nc(Br)ncc1N

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
UHRF1 Q96T88 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15184555 0.81 UHRF1 (0.39) UHRF1
SCHEMBL4736010 0.72
SCHEMBL13180943 0.68
SCHEMBL7418341 0.67 HTT (0.37)
SCHEMBL21317734 0.65 HTT (0.45) UHRF1
SCHEMBL27955980 0.64 UHRF1 (0.34) UHRF1
SCHEMBL7410605 0.61 AOC1 (0.42) UHRF1
SCHEMBL28171461 0.60 UHRF1 (0.31) UHRF1
SCHEMBL25225301 0.60 CCR4 (0.32)
SCHEMBL30497655 0.60 CCR4 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5002944-A Compounds having cardiotonic activity RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1991-03-26 US disclosed
EP-0333727-A1 HETEROCYCLIC SUBSTITUTED BICYCLOUREAS HAVING CARDIOTONIC ACTIVITY RORER INTERNATIONAL (OVERSEAS) INC. (a Delaware corporation) (US) 1989-09-27 EP disclosed
US-4859672-A Pyrido[2,3-d]pyrimidinone and imidazo[4,5-b]pyrimidinone RORER PHARMACEUTICAL CORPORATION (US) 1989-08-22 US disclosed
WO-1988003025-A1 HETEROCYCLIC SUBSTITUTED BICYCLOUREAS HAVING CARDIOTONIC ACTIVITY RORER INTERNATIONAL (OVERSEAS) INC. (US) 1988-05-05 WO disclosed